Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2eu peptide (E75) and GM-CSF vaccine★

著录项

• 来源
  《Breast Cancer Research and Treatment》 |2006年第1期|17-29|共13页
• 作者

  Matthew T. Hueman; Alexander Stojadinovic; Catherine E. Storrer; Rebecca J. Foley; Jennifer M. Gurney; Craig D. Shriver; Sathibalan Ponniah; George E. Peoples;

  展开▼
• 作者单位

  Clinical Breast Care Project Department of Surgery Walter Reed Army Medical Center;

  Clinical Breast Care Project Department of Surgery Walter Reed Army Medical CenterClinical Breast Care Project Immunology and Research Center Uniformed Services University of the Health Sciences;

  Clinical Breast Care Project Immunology and Research Center Uniformed Services University of the Health Sciences;

  Clinical Breast Care Project Immunology and Research Center Uniformed Services University of the Health Sciences;

  Clinical Breast Care Project Department of Surgery Walter Reed Army Medical Center;

  Clinical Breast Care Project Department of Surgery Walter Reed Army Medical CenterClinical Breast Care Project Immunology and Research Center Uniformed Services University of the Health Sciences;

  Clinical Breast Care Project Immunology and Research Center Uniformed Services University of the Health Sciences;

  Clinical Breast Care Project Department of Surgery Walter Reed Army Medical CenterClinical Breast Care Project Immunology and Research Center Uniformed Services University of the Health SciencesClinical Breast Care Project Immunology and Research Center Uniformed Services University of the Health Sciences;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词

  CD4+CD25+ T cells; E75; HER2eu; peptide vaccine; regulatory T cells;

  机译：CD4 + CD25 + T细胞;E75;HER2 / neu;肽疫苗;调节性T细胞;